Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 23 Jan 2025

Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis

in Renal Pharmacology

Xiaohui Meng
Li Sheng
Yongqing You
Huibo Dai
Manshu Yu
Funing Wang
Ziren Zhou
Yun Shan
Meixiao Sheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1515038

1,119 views

Review

Published on 22 Jan 2025

Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis

in Renal Pharmacology

Xiaoming Li
Rui Xu
Dan Zhang
Ji Cai
He Zhou
Tao Song
Xianyao Wang
Qinghong Kong
Liujin Li
Zhaohui Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511083

1,894 views

Original Research

Published on 21 Jan 2025

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway

in Renal Pharmacology

Yan Ye
Xiaopeng Huang
Xueying Li
Fei Gao
Wenzhen Zhong
Anqi Tang
Liangbin Zhao
Dengpiao Xie
Naijing Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453668

1,288 views

Editorial

Published on 21 Jan 2025

Editorial: Women in renal pharmacology 2023

in Renal Pharmacology

Nuria Lloberas
Laure Elens
Brenda de winter

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519295

762 views

Review

Published on 14 Jan 2025

Current status and prospects of traditional Chinese medicine combined with stem cell therapy for chronic kidney disease

in Renal Pharmacology

Tianyang Qian
Yining He
Chao Han
Ruxue Yan
Weiming He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505206

1,314 views

Original Research

Published on 13 Jan 2025

Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway

in Renal Pharmacology

Yiwen Cao
Huan Zhao
Shuyin Lin
Junqi Chen
Jingli Xiong
Zhijun Zeng
Ziyu Long
Yingru Su
Yingqi Zhong
Lingru Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503628

1,347 views
1 citation

Review

Published on 13 Jan 2025

Ferroptosis in kidney disease: a bibliometric analysis from 2012 to 2024

in Renal Pharmacology

Yuxin Hu
Jingyi Tang
Hanzhang Hong
Yexin Chen
Beibei Ye
Ziheng Gao
Gegongming Zhu
Lin Wang
Weijing Liu
Yaoxian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507574

1,794 views

Original Research

Published on 09 Jan 2025

Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database

in Renal Pharmacology

Peiyang Cao
Qian Wang
Yan Wang
Qing Qiao
Liyuan Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509310

1,639 views
1 citation

Original Research

Published on 07 Jan 2025

Research hotspots and frontiers of endoplasmic reticulum in glomerular podocytes: a bibliometric and visual analysis from 2005 to 2023

in Renal Pharmacology

Wang Junli
Hao Zhihong
Wang Lina
Ou Qiaoqun
Qu Jing
Hu Jiaqi
Shengyou Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488340

880 views

Review

Published on 07 Jan 2025

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

in Renal Pharmacology

Yan Li
Yuxin Zhang
Mengxia Cao
Tingting Yuan
Santao Ou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475198

1,076 views

Original Research

Published on 07 Jan 2025

High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury

in Renal Pharmacology

Sayantap Datta
Mohammad Atiqur Rahman
Saisudha Koka
Krishna M. Boini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1540639

1,952 views
1 citation

Correction

Published on 06 Jan 2025

Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

in Renal Pharmacology

Guangzhuang Li
Sentao Xian
Xianchao Cheng
Yunhua Hou
Wenqing Jia
Yukui Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1548193

688 views

Original Research

Published on 06 Jan 2025

The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience

in Renal Pharmacology

Xueting Li
Peng Yan
Lu Zhang
Wei Qiao
Zhengbiao Xue
Xiangdong Fang
Ben Ke
Shuying Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403562

796 views
2 citations

Original Research

Published on 06 Jan 2025

Curcumin nanocrystals ameliorate ferroptosis of diabetic nephropathy through glutathione peroxidase 4

in Renal Pharmacology

Mengjiao Xue
Yiwei Tian
Hua Zhang
Shijie Dai
Yangsheng Wu
Juan Jin
Jian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1508312

1,080 views

Systematic Review

Published on 03 Jan 2025

Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis

in Renal Pharmacology

Yuanchen Lv
Zibo Hua
Xiaomei Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511525

1,718 views

Original Research

Published on 03 Jan 2025

FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle

in Renal Pharmacology

Yudie Zhang
Fan Wang
Chongyang Zhang
Fan Yao
Bin Zhang
Yongping Zhang
Xiaobo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500458

1,145 views